Timothy F Burns
9PUBLICATIONS
94CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Mar 13, 2026
Pan-tumor activity of olomorasib, a next-generation KRAS G12C inhibitor in KRAS G12C-mutant advanced solid tumors: a first-in-human study.Yonina R Murciano-Goroff, Antoine Hollebecque, Rebecca S Heist
|Oct 29, 2025
Phase 1 clinical trial of the ataxia telangiectasia and Rad3-related inhibitor berzosertib with irinotecan in patients with advanced solid tumors (ETCTN 9938).Liza C Villaruz, Jingxiao Jin, Hong Wang
|Dec 09, 2024
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer.Mitchell S von Itzstein, Timothy F Burns, Jonathan E Dowell
|Jun 26, 2024
A Phase II Trial of the WEE1 Inhibitor Adavosertib in SETD2-Altered Advanced Solid Tumor Malignancies (NCI 10170).Edward Maldonado, W Kimryn Rathmell, Geoffrey I Shapiro
Pageof 2
Frequent Collaborators
1 joint publications
Shirish M Gadgeel
1 joint publications
Jieling Miao
1 joint publications
Jonathan W Riess
1 joint publications
James Moon
1 joint publications
Philip C Mack
1 joint publications
Gregory J Gerstner
1 joint publications
Asma Taj
1 joint publications
Wallace L Akerley
1 joint publications
Konstantin H Dragnev
1 joint publications
Noel Laudi